Administered intravenously, the monoclonal antibody MK-2060 has a "novel approach" to anticoagulation by blocking the ...

Panelists discuss how ADA recommendations emphasize treating diabetes as part of overlapping conditions requiring cardiovascular and kidney protection, moving beyond just glycemic control to ...

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

HistoSonics plans to use data from the trial’s 90-day evaluation point to support its regulatory clearance with the FDA.

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

A major international study presented at the 62nd ERA Congress reveals that the long-accepted survival advantage of ...

A major international study, being presented today at the 62nd ERA Congress, reveals that the long-accepted survival ...

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant.

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika ...

Representativeness Of Pivotal Clinical Trials Disease burden information was available for 225 (232 drug-indication combinations) of the 290 drugs (appendix exhibit A3). 11 These 225 drugs ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...